Helus Pharma Inc. (HELP) vs Solid Biosciences Inc. (SLDB)
A side-by-side comparison of Helus Pharma Inc. and Solid Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HELP
Helus Pharma Inc.
$10.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SLDB
Solid Biosciences Inc.
$6.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HELP vs SLDB
growth of $100 · dividends reinvested · last 1yHELP +93.2% (+93.2%/yr)SLDB +23.6% (+23.6%/yr)HELP compounded faster over this window
HELP SLDB
HELP vs SLDB: by the numbers
- •SLDB is the larger company ($681M vs $667M market cap).
- •HELP is profitable (329.09% net margin) while SLDB runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | HELP | SLDB |
|---|---|---|
| P/B ratio | 2.76 | 1.82 |
Profitability
| Metric | HELP | SLDB |
|---|---|---|
| Gross margin | 100.27% | 0.00% |
| Operating margin | 317.06% | 0.00% |
| Net margin | 329.09% | 0.00% |
| ROE | -75.79% | -55.36% |
| ROIC | -73.27% | -54.12% |
Growth (annualized)
| Metric | HELP | SLDB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -27.50% |
Frequently asked
- Is HELP or SLDB more profitable?
- HELP runs the higher net margin — HELP at 329.09% versus SLDB at 0.00%.
Go deeper
Dig into the metrics
Helus Pharma ROESolid Biosciences ROEHelus Pharma operating marginSolid Biosciences operating marginHelus Pharma revenue growthSolid Biosciences revenue growthHelus Pharma free cash flowSolid Biosciences free cash flow
Helus Pharma & Solid Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.